Ignite Creation Date:
2025-12-24 @ 9:38 PM
Ignite Modification Date:
2026-05-01 @ 1:21 PM
Study NCT ID:
NCT01408732
Status:
COMPLETED
Last Update Posted:
2019-11-01
First Post:
2011-07-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Sponsor:
University of Minnesota
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1101M95232
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |